Literature DB >> 29880989

One-step, stereoselective synthesis of octahydrochromanes via the Prins reaction and their cannabinoid activities.

Shuneize Slater1, Pradeep B Lasonkar1, Saqlain Haider1, Moneerah J Alqahtani2, Amar G Chittiboyina1, Ikhlas A Khan1,2.   

Abstract

Novel, functionalized octahydrochromene derivatives were synthesized in a single step via the Prins reaction. Enantiomerically pure (+)-isopulegol was reacted with benzaldehyde to stereoselectively yield the corresponding octahydro-2H-chromen-4-ol derivative containing five stereocenters. A total of 10 compounds were synthesized by altering the enantiomer of isopulegol and the substituted benzaldehyde, and the resulting enantiopure octahydrochromenes were screened in vitro against the cannabinoid receptor isoforms CB1 and CB2. Compounds containing an olefin at the C4 position [(+)-3c, (-)-3c, (-)-7c, (-)-9c and (-)-11c] of the octahydrochromene scaffold were found to exhibit reasonable displacement of [3H] CP55,940 from the CB receptors, whereas the corresponding hydroxy analogs [(+)-3a, (+)-3b, (-)-3a, (-)-3b and (+)-5a] had very little or no effect.

Entities:  

Keywords:  Cannabinoid receptors; Enantioselectivity; Octahydrochromene; Prins cyclization

Year:  2018        PMID: 29880989      PMCID: PMC5986293          DOI: 10.1016/j.tetlet.2018.01.040

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  10 in total

1.  Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.

Authors:  Anju Preet; Zahida Qamri; Mohd W Nasser; Anil Prasad; Konstantin Shilo; Xianghong Zou; Jerome E Groopman; Ramesh K Ganju
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-19

Review 2.  Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects.

Authors:  K R Patil; S N Goyal; C Sharma; C R Patil; S Ojha
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

3.  Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists.

Authors:  Sari Yrjölä; Mirkka Sarparanta; Anu J Airaksinen; Maria Hytti; Anu Kauppinen; Sanna Pasonen-Seppänen; Barbara Adinolfi; Paola Nieri; Clementina Manera; Outi Keinänen; Antti Poso; Tapio J Nevalainen; Teija Parkkari
Journal:  Eur J Pharm Sci       Date:  2014-11-14       Impact factor: 4.384

4.  Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.

Authors:  Dinesh Thapa; Jong Suk Lee; Se-Woong Heo; Yong Rok Lee; Keon Wook Kang; Mi-Kyoung Kwak; Han Gon Choi; Jung-Ae Kim
Journal:  Eur J Pharmacol       Date:  2010-10-13       Impact factor: 4.432

5.  Selective, nontoxic CB(2) cannabinoid o-quinone with in vivo activity against triple-negative breast cancer.

Authors:  Paula Morales; Sandra Blasco-Benito; Clara Andradas; María Gómez-Cañas; Juana María Flores; Pilar Goya; Javier Fernández-Ruiz; Cristina Sánchez; Nadine Jagerovic
Journal:  J Med Chem       Date:  2015-02-20       Impact factor: 7.446

6.  In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.

Authors:  R Abalo; C Chen; G Vera; J Fichna; G A Thakur; A E López-Pérez; A Makriyannis; M I Martín-Fontelles; M Storr
Journal:  Neurogastroenterol Motil       Date:  2015-09-20       Impact factor: 3.598

7.  Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.

Authors:  Nicholas A Jones; Andrew J Hill; Imogen Smith; Sarah A Bevan; Claire M Williams; Benjamin J Whalley; Gary J Stephens
Journal:  J Pharmacol Exp Ther       Date:  2009-11-11       Impact factor: 4.030

Review 8.  Cannabidiol and epilepsy: Rationale and therapeutic potential.

Authors:  Antonio Leo; Emilio Russo; Maurizio Elia
Journal:  Pharmacol Res       Date:  2016-03-11       Impact factor: 7.658

9.  A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro.

Authors:  Priyadharishini Veeraraghavan; Ana Dekanic; Andrea Nistri
Journal:  Neuroscience       Date:  2016-07-20       Impact factor: 3.590

10.  In vitro opioid receptor affinity and in vivo behavioral studies of Nelumbo nucifera flower.

Authors:  Mallika Kumarihamy; Francisco León; Sara Pettaway; Lisa Wilson; Janet A Lambert; Mei Wang; Christopher Hill; Christopher R McCurdy; Mahmoud A ElSohly; Stephen J Cutler; Ilias Muhammad
Journal:  J Ethnopharmacol       Date:  2015-08-07       Impact factor: 4.360

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.